1. Home
  2. ALBT vs ZBAI Comparison

ALBT vs ZBAI Comparison

Compare ALBT & ZBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALBT
  • ZBAI
  • Stock Information
  • Founded
  • ALBT 2014
  • ZBAI 2015
  • Country
  • ALBT United States
  • ZBAI United States
  • Employees
  • ALBT N/A
  • ZBAI N/A
  • Industry
  • ALBT Biotechnology: Biological Products (No Diagnostic Substances)
  • ZBAI Professional Services
  • Sector
  • ALBT Health Care
  • ZBAI Consumer Discretionary
  • Exchange
  • ALBT Nasdaq
  • ZBAI Nasdaq
  • Market Cap
  • ALBT 7.4M
  • ZBAI 6.5M
  • IPO Year
  • ALBT N/A
  • ZBAI N/A
  • Fundamental
  • Price
  • ALBT $2.33
  • ZBAI $6.71
  • Analyst Decision
  • ALBT
  • ZBAI
  • Analyst Count
  • ALBT 0
  • ZBAI 0
  • Target Price
  • ALBT N/A
  • ZBAI N/A
  • AVG Volume (30 Days)
  • ALBT 64.7K
  • ZBAI 33.5K
  • Earning Date
  • ALBT 08-14-2025
  • ZBAI 06-06-2025
  • Dividend Yield
  • ALBT N/A
  • ZBAI N/A
  • EPS Growth
  • ALBT N/A
  • ZBAI N/A
  • EPS
  • ALBT N/A
  • ZBAI N/A
  • Revenue
  • ALBT $1,159,091.00
  • ZBAI $720,000.00
  • Revenue This Year
  • ALBT N/A
  • ZBAI N/A
  • Revenue Next Year
  • ALBT N/A
  • ZBAI N/A
  • P/E Ratio
  • ALBT N/A
  • ZBAI N/A
  • Revenue Growth
  • ALBT N/A
  • ZBAI 44.00
  • 52 Week Low
  • ALBT $1.87
  • ZBAI $4.83
  • 52 Week High
  • ALBT $11.66
  • ZBAI $45.00
  • Technical
  • Relative Strength Index (RSI)
  • ALBT 54.41
  • ZBAI 55.39
  • Support Level
  • ALBT $2.04
  • ZBAI $5.65
  • Resistance Level
  • ALBT $2.19
  • ZBAI $6.43
  • Average True Range (ATR)
  • ALBT 0.15
  • ZBAI 0.60
  • MACD
  • ALBT 0.04
  • ZBAI 0.19
  • Stochastic Oscillator
  • ALBT 79.68
  • ZBAI 75.03

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

About ZBAI ATIF Holdings Limited Ordinary Shares

ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.

Share on Social Networks: